Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic comparison of Wilate and Haemate P in type 3 von Willebrand disease
2008-001910-25Phase 2Completed
- Sponsor
- Octapharma
- Start
- May 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of von Willebrand factor concentrate and Haemate P in Type 3 von Willebrand disease (2 arms), sponsored by Octapharma. Primary endpoint: In-vivo half-life of Wilate. Started May 2008; status: completed.
02
Drugs
von Willebrand factor concentrateHaemate P
03
Conditions
Type 3 von Willebrand disease
Beyond the preview
Go deeper on 2008-001910-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001910-25.